Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0352 were derived from the same patient.
英文に準拠、生物遺伝資源提供同意書 (MTA) には、英文をご記載またはご添付ください。先ずは、<a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line 問い合わせ&">理研細胞バンク</a>にお問い合わせください 。
疾患特異的iPS細胞株。封入体筋炎患者由来。HPS0351、HPS0352と同一人由来。レトロウイルスベクターを用いて5因子（pDON-5 Oct3/4-Sox2, pDON-5 Klf4, pDON-5 LIN28-NANOG）を導入して樹立。<a href='http://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。
VCP-#4
HPS0353
疾患特異的iPS細胞株。封入体筋炎患者由来。HPS0351、HPS0352と同一人由来。レトロウイルスベクターを用いて5因子（pDON-5 Oct3/4-Sox2, pDON-5 Klf4, pDON-5 LIN28-NANOG）を導入して樹立。<a href='https://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。
Disease specific iPS cell line derived from a patient : Inclusion body myositis. HPS0351 and HPS0352 were derived from the same patient. Order Form (C-0042, C-0057, C-0007 or C-0007p).
1) In relation to the for-profit organizations, please access to the following URL and consult 'iPS Academia Japan, Inc.' (http://ips-cell.net/e/index.php) prior to the utilization of iPS cells. 2) Collaboration with the depositor is necessary. 3) The DEPOSITOR developed the BIOLOGICAL RESOURCE (iPS cell lines) with the cells obtained from the NIGMS Human Genetic Cell Repository (the Repository ID numbers is GM22394) . The RECIPIENT who obtained the BIOLOGICAL RESOURCE from the RIKEN BRC must acknowledge the NIGMS Human Genetic Cell Repository and the cell line number in any publications or presentations based on the utilization of the NIGMS Repository Sample as follows:'HPS0351 was derived from cell line GM22394 from the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research.' 4) Contact Us : <a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line&">RIKEN Cell Bank</a>